It is a healthcare private limited company based in Patancheru, Telangana, India, established in 2021.
2021 | Patancheru, Telangana, India | ActiveCytobiologics Private Limited, a active private limited company, was established on 10 May 2021 in Patancheru, Telangana, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U24290TG2021PTC151278. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.21 Cr.
Employing 139 professional, Its leadership includes Rajesh Reddy Tummuru (Director), Gopi Siva Krishna Lekkala (Director), Jeevan Sivakrishna Lekkala (Director). Past directors included Jeevan Sivakrishna Lekkala. It holds ₹37.24 Cr open charges and ₹18.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sy No. 70, 174 Plot No. M4, Medical Device Park, Ameenpur, Sangareddy, Patancheru, Telangana, 502319.
U24290TG2021PTC151278
151278
10 May 2021
₹2.00 Cr
₹1.21 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Cytobiologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Reddy Tummuru | Director | 10 May 2021 | Current |
| Gopi Siva Krishna Lekkala | Director | 10 May 2021 | Current |
| Jeevan Sivakrishna Lekkala | Director | 30 Aug 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Mar 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cytobiologics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 8000.43% increase. The company also saw a substantial improvement in profitability, with a 4619.49% increase in profit. The company's net worth Soared by an impressive increase of 2377.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Cytobiologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹372,380,000.00
₹180,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jul 2024 | Axis Bank Limited | ₹1.16 Cr | Open |
| 29 Dec 2023 | Others | ₹36.08 Cr | Open |
| 03 Dec 2022 | Others | ₹3.00 Cr | Satisfied |
| 16 Sep 2021 | Others | ₹15.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Cytobiologics has a workforce of 139 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cytobiologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytobiologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 36.08 Cr registered on 29 Dec 2023 with Charge ID 100851872 was modified on 28 May 2025. was completed.
Cytobiologics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 1.16 Cr with Charge ID 100973975 was registered on 22 Jul 2024. was completed.
The activity Cytobiologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on A charge registered on 03 Dec 2022 via Charge ID 100664034 with Others was fully satisfied on 12 Feb 2024. was documented.
The activity A charge registered on 16 Sep 2021 via Charge ID 100509487 with Others was fully satisfied on 12 Feb 2024. was completed.
The CIN of Cytobiologics Private Limited is U24290TG2021PTC151278.
Cytobiologics Private Limited is headquartered at Sy No. 70, 174 Plot No. M4, Medical Device Park, Ameenpur, Sangareddy, Patancheru, Telangana, 502319.
Cytobiologics Private Limited was incorporated on 10 May 2021.
The current directors of Cytobiologics Private Limited are
The primary industry of Cytobiologics Private Limited is Manufacturing.
Cytobiologics Private Limited is unlisted.
The authorized capital of Cytobiologics Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.21 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX